-
became CEO. On 6
January 2012
board member Michael Hunkapiller, PhD ****umed the role of CEO.
Hunkapiller retired in
September 2020, and was
replaced by chairman...
-
information is
acquired directly by computer.
Smith LM, Fung S,
Hunkapiller MW,
Hunkapiller TJ, Hood LE (April 1985). "The
synthesis of oligonucleotides...
- 1038/321674a0. PMID 3713851. S2CID 27800972. Smith, L M; Fung, S;
Hunkapiller, M W;
Hunkapiller, T J; Hood, L E (April 11, 1985). "The
synthesis of oligonucleotides...
- 1016/S0021-9258(18)36051-4. PMID 468807. Zoon KC,
Smith ME,
Bridgen PJ,
Anfinsen CB,
Hunkapiller MW, Hood LE (February 1980). "Amino
terminal sequence of the
major component...
- on 19
August 2018.
Retrieved 2
March 2023. Chait, Edward; Page, Guy;
Hunkapiller,
Michael (1988). "Battle of the DNA sequencers". Nature. 333 (6172):...
- Compendium.
January 2017.
Retrieved April 21, 2018.
McIntosh M, Cruz LJ,
Hunkapiller MW, Gray WR,
Olivera BM (1982). "Isolation and
structure of a peptide...
- equipment.
Hunkapiller brought in Dr. J.
Craig Venter to
direct the project. Tony White,
president of the Perkin-Elmer
Corporation backed Hunkapiller on the...
-
Michael W.
Hunkapiller (Applied Biosystems) For his
contribution to the
development of the
automated high-throughput DNA
sequencers and the promotion...
-
Surti U,
Sandstrom R,
Boitano M,
Landolin JM,
Stamatoyannopoulos JA,
Hunkapiller MW,
Korlach J,
Eichler EE (January 2015). "Resolving the
complexity of...
-
NASDAQ exchange, as it
became a
division of Perkin-Elmer.
Michael W.
Hunkapiller, Ph.D., who had been
Applied Biosystem's chairman,
president and CEO...
